News & Events

News and Upcoming Events

DCVMN Webinar  - January 21st 2021: A Novel Method for Rapidly Assessing Potency of Measles and Rubella Vaccines
A Novel Method for Rapidly Assessing Potency of Measles and Rubella Vaccines

Online

January 21, 2021, 5:00 pm CET
Read More

Past News and Events

On-Demand DCVMN Webinar: Rapid Analytics for Vaccines using InDevR’s VaxArray Platform We Invite you to view our free recorded webinar (occurred live on September 15th 2020)  to learn more about VaxArray ...
Read More
On-Demand World Vaccine Washington Webinar: Accelerating Development of COVID-19 Vaccines Using InDevR's Novel VaxArray Coronavirus SeroAssay We Invite you to view our free recorded webinar (occurred live on July 14th ...
Read More
On-Demand Webinar: Accelerating Development of COVID-19 Vaccines Using InDevR's Novel VaxArray Coronavirus SeroAssay We Invite you to our free recroded webinar (occurred live on June 30th 2020) to learn about ...
Read More
InDevR Delivers Commercial Multiplex Coronavirus SeroAssay Kit and Testing Services for Vaccine Development Boulder, CO – June 17, 2020– InDevR, Inc., a leader in novel analytical technologies that support the ...
Read More
InDevR Ships First Multiplexed COVID-19 Serology Test Kits for Clinical Validation Boulder, CO-9 April 2020– InDevR, Inc., a leader in progressive analytical technologies to support the development and production of ...
Read More
InDevR Raises $7 million in Series A Financing with Adjuvant Capital Boulder, CO, 10 September 2019 – InDevR, Inc., a biotechnology company focused on developing and commercializing novel analytical technologies ...
Read More